Tft. Antonios et Ga. Macgregor, ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN HYPERTENSION - POTENTIAL PROBLEMS, Journal of hypertension, 13, 1995, pp. 11-16
Aim: To review potential problems associated with the use of angiotens
in converting enzyme (ACE) inhibitors in the treatment of patients wit
h hypertension. Physiological problems: ACE inhibitors cause a drop in
blood pressure depending on the circulating level of angiotensin II.
This may be a problem in patients with severe congestive heart failure
, so that it is important to monitor the effect of the ACE inhibitor i
n this group. Hyperkalaemia can develop in patients wth severe renal i
mpairment and potassium plasma levels should be monitored. Renal impai
rment is another potential problem and in hypertensive patients renal
function should be measured before, and a few weeks after, starting tr
eatment. This is especially important when there is any possibility of
fibromuscular hyperplasia or atheroscerotic renal artery stenosis. No
n-physiological problems: In addition to a cough, which is the most co
mmon problem, skin rashes, loss of taste, haematological effects and a
ngioneurotic oedema are also encountered. The incidence of a cough wit
h most ACE inhibitors is 5-10%. Conclusions: Compared to other antihyp
ertensive drugs, ACE inhibitors have the major advantage of being well
tolerated by most patients with few side effects.